
    
      This is a single center, open-label, randomized, pilot clinical trial. Women with polycystic
      ovary syndrome and depressed mood, who are insulin resistant and vitamin D insufficient are
      eligible. Subjects are randomly assigned to one of two interventions: Vitamin D versus
      metformin. Subjects are followed with questionnaires and a final wrap-up clinic visit with a
      physician. The study duration is 12 weeks.
    
  